We use cookies for a better user experience. Click here to know more about it. 


Global Darbepoetin Alfa Market Insights and Forecast to 2027

Lowest Price Available Length Published Date Report Id
from $4900.00 102 Pages 2021-07-27 2625016


Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.

Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.

North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.

Market competition is not intense. Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Novartis and 3SBio etc. are the leaders of the industry, with about 87% market shares.

Market Analysis and Insights: Global Darbepoetin Alfa Market

The global Darbepoetin Alfa market size is projected to reach US$ 4135.7 million by 2027, from US$ 5073.6 million in 2020, at a CAGR of -2.8% during 2021-2027.

Global Darbepoetin Alfa Scope and Segment

Darbepoetin Alfa market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Darbepoetin Alfa market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

The following manufacturers are covered in this report:


Johnson & Johnson

Kyowa Hakko Kirin



Darbepoetin Alfa Breakdown Data by Type





Darbepoetin Alfa Breakdown Data by Application

Patients with Chronic Kidney Disease

Patients with Cancer


Regional and Country-level Analysis

The Darbepoetin Alfa market is analysed and market size information is provided by regions (countries).

The key regions covered in the Darbepoetin Alfa market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.

Licenses Type

Only one user can access the report
Multiple users can access the report

Need Help ?